Pharma: Other News To Note
Wednesday, May 9, 2012
Clinigen Healthcare, of Burton-on-Trent, UK, the pharmaceutical products division of Clinigen Group, said its supplemental new drug application for Foscavir (foscarnet sodium) in HIV/AIDS-related cytomegalovirus infections and herpes was approved by the FDA.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.